GL1X · GenesisL1 explorer

Research workbench

Crystal structure of transthyretin in complex with ligand C-7

Analyse Crystal structure of transthyretin in complex with ligand C-7 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4AC2
Type
protein
Length
230 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
43F
Pockets
2 · best druggability 0.33

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTransthyretinprotein1156% helix, 53% strandP02766

Ligands and binding sites

  • 43F · 2,4-dichloro-1-[4-(chloromethyl)-2-methoxyphenoxy]benzene · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1640.330.7616empty
2700.320.7513empty

Interfaces

1 interface between chains.

  • A–B · 936 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 4AC2 · Crystal structure of transthyretin in complex with ligand C-7 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.